Latest News and Press Releases

Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates

Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results

Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025

Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025

BALTIMORE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals, a pioneer in non-degrading molecular glue therapeutics, announced today that it will host an executive roundtable at the WuXi...

Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Global Targeted Protein Degradation Market by Type, by Application, by End-User, and by Region" report has been added to ResearchAndMarkets.com's...

Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Targeted Protein Degradation Market Size, Share & Trends Analysis by Type (PROTAC, LYTACs), Application (Drug Discovery), End Use (Hospitals,...

Monte Rosa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference

SAB Comprised of Pioneers in the Field of Protein Degradation, Including Unique Expertise in Roles of Ubiquitin Biology and Translational Medicine Track Records of Founding Biopharma Companies and...